AMANDA SANFORD: Open Payments
NPI 1427787498 · NEW BREMEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 28 payments from 11 companies in 2025. Trend: 2023 $626 · 2024 $376 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $102 |
| ABBVIE INC. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Novo Nordisk Inc | 3 | $67 |
| Abbott Laboratories | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: NURTEC ODT, QULIPTA, Ozempic, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
